[go: up one dir, main page]

WO2017082253A1 - Capteur - Google Patents

Capteur Download PDF

Info

Publication number
WO2017082253A1
WO2017082253A1 PCT/JP2016/083127 JP2016083127W WO2017082253A1 WO 2017082253 A1 WO2017082253 A1 WO 2017082253A1 JP 2016083127 W JP2016083127 W JP 2016083127W WO 2017082253 A1 WO2017082253 A1 WO 2017082253A1
Authority
WO
WIPO (PCT)
Prior art keywords
electrode
detection element
sensor
semiconductor
semiconductor layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2016/083127
Other languages
English (en)
Japanese (ja)
Inventor
和真 長尾
井口　雄一朗
村瀬　清一郎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toray Industries Inc
Original Assignee
Toray Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries Inc filed Critical Toray Industries Inc
Priority to JP2017550336A priority Critical patent/JPWO2017082253A1/ja
Publication of WO2017082253A1 publication Critical patent/WO2017082253A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/02—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating impedance
    • G01N27/04—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating impedance by investigating resistance
    • G01N27/12—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating impedance by investigating resistance of a solid body in dependence upon absorption of a fluid; of a solid body in dependence upon reaction with a fluid, for detecting components in the fluid
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/403—Cells and electrode assemblies
    • G01N27/414—Ion-sensitive or chemical field-effect transistors, i.e. ISFETS or CHEMFETS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/416—Systems
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Definitions

  • the present invention relates to a sensor capable of simultaneously measuring a plurality of biological substances.
  • glycated hemoglobin hereinafter also referred to as HbA1c
  • glycoalbumin glycated albumin
  • glycated protein In diabetes, the production of glycated protein is enhanced, and the concentration of HbA1c contained in erythrocytes and glycoalbumin in serum reflect the average blood glucose level over a certain period in the past.
  • Glucose shows the current blood glucose state
  • glycoalbumin reflects the blood glucose state about 1 to 2 weeks ago
  • HbA1c reflects the blood glucose state about 1 to 2 months ago. Therefore, measurement of these glycated proteins is important for the time-dependent diagnosis or symptom management of diabetes symptoms in that the blood glucose concentration can be determined over time. Therefore, as an index for diabetes management, there is a demand for a rapid and accurate quantitative method for glucose concentration and HbA1c or glycoalbumin.
  • an electrochemical detection method As a method for measuring glucose in a biological fluid, for example, there is an electrochemical detection method called an enzyme electrode method.
  • an electrochemical detection method called an enzyme electrode method.
  • information correlated with the glucose concentration in the biological sample is output to an electrode in contact with the biological sample, and the glucose concentration is calculated based on this output. Since the enzyme electrode method can be applied to a small blood glucose level sensor, it is mainly used by diabetic patients all over the world.
  • a method for measuring HbA1c for example, a chromatography method such as HPLC, an immunoassay method using an antibody such as latex immunoagglutination, and an enzyme method using an enzyme that acts on a glycated protein are known. Both are widely used in clinical settings as detection methods using light.
  • an object of the present invention is to provide a small sensor capable of simultaneously measuring glucose and biologically related substances other than glucose such as HbA1c and glycoalbumin.
  • the present invention has the following configuration. 1. It has at least a first detection element that detects glucose in a biological fluid and a second detection element that detects a biological substance other than glucose, and the second detection element includes a semiconductor element. Sensor. 2. 2. The sensor according to 1 above, wherein the biological substance is glycated hemoglobin or glycated albumin. 3. 3. The sensor according to 1 or 2, further comprising a third detection element, wherein the third detection element detects hemoglobin. 4). 4. The sensor according to 3 above, wherein the third detection element includes a semiconductor element. 5). 5. The sensor according to any one of 1 to 4, wherein a detection part area of the second detection element is twice or more a detection part area of the third detection element. 6). 6.
  • the semiconductor element includes at least a substrate, a first electrode, a second electrode, and a semiconductor layer, and the first electrode and the second electrode each include a metal type of 80 wt% or more, a double-walled carbon nanotube, 7.
  • the semiconductor layer contains carbon nanotubes.
  • a conjugated polymer is attached to at least a part of the surface of the carbon nanotube. 10.
  • 11. The sensor according to any one of 1 to 10, wherein the sensor has a biological fluid inlet, and a path connecting the inlet to the first detection element and the second detection element.
  • 12 The sensor according to any one of 1 to 11, wherein the biological fluid is blood.
  • the path has a space for mixing the blood and a hemolytic agent between the blood inlet and the second detection element.
  • a small sensor capable of simultaneously measuring a plurality of biological substances can be provided.
  • FIG. 1 is a perspective view showing an embodiment of the sensor of the present invention.
  • FIG. 2 is a schematic cross-sectional view showing an example of a semiconductor element.
  • FIG. 3 is a schematic cross-sectional view showing an example of a semiconductor element.
  • FIG. 4 is a schematic cross-sectional view showing an example of a semiconductor element.
  • FIG. 5A is a schematic cross-sectional view illustrating an example of a semiconductor element.
  • FIG. 5B is a cross-sectional view taken along line CC ′ of FIG. 5A.
  • FIG. 6A is a schematic cross-sectional view illustrating an example of a semiconductor element. 6B is a cross-sectional view taken along line DD ′ of FIG. 6A.
  • FIG. 7 is a schematic cross-sectional view showing an example of a semiconductor element.
  • FIG. 8 is a perspective view showing an embodiment of the sensor of the present invention.
  • FIG. 9 is a perspective view showing an embodiment of the sensor of the present invention.
  • the sensor of the present invention has at least a first detection element for detecting glucose in a biological fluid and a second detection element for detecting a biological substance other than glucose, and the second detection element is a semiconductor. Including elements.
  • FIG. 1 is a schematic perspective view of a sensor having a first detection element 401 and a second detection element 402.
  • the two detection elements are both formed on the substrate 10 and are bonded to the upper substrate 20 to form a chip.
  • the first detection element 401 detects glucose in the biological fluid.
  • the first detection element 401 includes at least a pair of electrodes 101 on the substrate 10 and a reaction layer 110 between the pair of electrodes.
  • the pair of electrodes are detection electrodes and are electrically connected to the connection portion 102 and the wiring 107. Using this connection, a voltage can be applied between the electrodes from a power source connected to the connection part, or an electric signal generated in the reaction layer can be taken out from the connection part.
  • the reaction layer contains an enzyme that reacts with glucose.
  • glucose in the biological fluid reacts with the enzyme in the reaction layer, the glucose is decomposed and further oxidized to produce hydrogen peroxide. Since the current when hydrogen peroxide is decomposed depends on the blood glucose concentration, the amount of current is detected as the glucose concentration.
  • the enzyme that reacts with glucose is not particularly limited, and examples thereof include glucose oxidase (GOD) and glucose dehydrogenase (GDH).
  • GOD glucose oxidase
  • GDH glucose dehydrogenase
  • reaction layer may contain a mediator in addition to the above enzyme.
  • the mediator temporarily receives electrons generated when glucose is decomposed, and then emits electrons when a voltage is applied between the pair of electrodes. Since the amount of current generated thereby depends on the blood glucose concentration, the amount of current is detected as the glucose concentration.
  • the mediator examples include various ions, and specific examples include ions generated from ferricyanide salts, ferrocene and derivatives thereof, methylene blue, benzoquinone and derivatives thereof, naphthoquinone, phenazine methosulfate, and thionine. Particularly preferred is ferricyan ion derived from potassium ferricyanide. When the ferricyan ion receives the electron, it is converted into ferrocyanide ion, and then returns to ferricyan ion again by applying a voltage.
  • the method using this detection element is generally called an electrode method using electrochemistry and is the mainstream of blood glucose level measuring instruments in recent years.
  • an electrode method using electrochemistry is the mainstream of blood glucose level measuring instruments in recent years.
  • the enzyme to be reacted there are a glucose oxidase method (GOD method), a glucose dehydrogenase method (GDH method) and the like, and any enzyme may be used as long as it is an electrode method.
  • Advantages of the electrode method include a short time until measurement, a small amount of blood to be collected, and a simple and easy-to-understand apparatus.
  • Examples of the material used for the substrate include inorganic materials such as silicon wafer, glass, and alumina sintered body, polyimide, polyester, polycarbonate, polysulfone, polyethersulfone, polyethylene, polyphenylene sulfide, polyparaxylene, aliphatic polyester, Examples include, but are not limited to, organic materials such as polyethylene terephthalate, polybutylene terephthalate, polypropylene, polyvinyl alcohol, polyvinyl chloride, polyvinylidene fluoride, polysiloxane, polyvinylphenol, and polyaramide, or a mixture of inorganic material powder and organic material. Is not to be done. These materials may be used alone, or a plurality of materials may be laminated or mixed.
  • Examples of the material used for the electrode include conductive metal oxides such as tin oxide, indium oxide, and indium tin oxide (ITO), or platinum, gold, silver, copper, iron, tin, zinc, aluminum, indium, Metals such as chromium, lithium, sodium, potassium, cesium, calcium, magnesium, palladium, molybdenum, amorphous silicon, and polysilicon and their alloys, inorganic conductive materials such as copper iodide and copper sulfide, polythiophene, polypyrrole, Polyaniline, organic conductive materials such as polyethylenedioxythiophene and polystyrenesulfonic acid complexes, glassy carbon, amorphous carbon, graphite, carbon fiber, and other carbon materials such as diamond, carbon nanotube, and graphene Nano-carbon material, such as, and the like conductive carbon black, but is not limited thereto.
  • conductive metal oxides such as tin oxide, indium oxide, and indium tin oxide (
  • Electrode materials may be used alone, or a plurality of materials may be laminated or mixed.
  • the electrode is preferably selected from gold, platinum, palladium, an organic conductive material, and a nanocarbon material from the viewpoint of stability to an aqueous solution in contact with the sensor.
  • the electrode may be in direct contact with the substrate, or may have an adhesive layer between the electrode and the substrate.
  • the adhesive layer also serves as an insulating layer that can be electrically insulated, a metallic or semiconducting substance can be used as the substrate.
  • the material used for the connecting portion may be any conductive material that can generally be used as an electrode. Specific examples include, but are not limited to, carbon materials, metals, alloys, various compounds of metals and alloys (eg, oxides, hydroxides, halides, sulfides, nitrides, and carbides). It is not something.
  • a carbon material platinum, palladium, gold, silver, aluminum or the like is used.
  • the carbon material include CNT, graphite, pyrolytic carbon, glassy carbon, acetylene black, and carbon black.
  • the material used for the wiring may be any conductive material that can be generally used as an electrode. Specific examples include, but are not limited to, carbon materials, metals, alloys, various compounds of metals and alloys (eg, oxides, hydroxides, halides, sulfides, nitrides, and carbides). It is not something.
  • a carbon material platinum, palladium, gold, silver, aluminum or the like is used.
  • the carbon material include CNT, graphite, pyrolytic carbon, glassy carbon, acetylene black, and carbon black.
  • the second detection element 402 detects a biological substance other than glucose.
  • the second detection element 402 includes a semiconductor element including at least a first electrode 103 and a second electrode 104 on the substrate 10 and a semiconductor layer 111 between the electrodes.
  • the first electrode and the second electrode are detection electrodes, and are electrically connected to the connection portion 102 and the wiring 107.
  • a power source and a detection unit are connected to the connection unit 102. Using this connection, a voltage can be applied between the electrodes from the power source, and an electrical signal generated in the semiconductor layer can be taken out from the connection portion.
  • the current value or the electric resistance value flowing between the first electrode and the second electrode changes. By measuring the change, the biological substance can be detected. By changing the substance that selectively interacts with the biological substance contained in the semiconductor layer, various biological substances can be detected.
  • a detection element using a semiconductor element include a short time until measurement, a small amount of blood to be collected, and a simple and easy-to-understand apparatus.
  • the FET type detection element is preferable in that labeling with a phosphor or the like is unnecessary, electrical signal conversion is fast, and connection with an integrated circuit is easy.
  • the first detection element has the same characteristics and size as the sensor chip of the blood glucose sensor, and is therefore equivalent to the current chip size and small. Further, the second detection element has the same size, but has a channel and is slightly larger.
  • the size of the sensor having these two is at least larger than the current blood glucose level sensor chip size, but is not as large as the device described in Patent Document 1.
  • the measurement of glucose is an electrochemical method mainly using an electrode method
  • the measurement of biological materials other than glucose is an electrical method using a semiconductor element. Both of them are preferable in that they do not use light, so that electrical signal conversion is fast and integration is easy.
  • the first detection element and the second detection element are provided with a common substrate 10, but may be provided with different substrates.
  • the material used for the upper substrate 20 the same material as that used for the substrate 10 can be used. In one sensor, the material of the substrate 10 and the upper substrate 20 may be the same or different.
  • a third detection element 403 may be provided in addition to the first and second detection elements.
  • the third detection element 403 detects hemoglobin.
  • the third detection element 403 includes at least (I) a pair of electrodes 121 on the substrate 10 and a reaction layer 112 between the pair of electrodes, or as shown in FIG. (II) An element having the first electrode 122 and the second electrode 123 and the semiconductor element 202 including the semiconductor layer 201 between these electrodes.
  • the ratio of HbA1c or the ratio of glycohemoglobin to the total hemoglobin can be calculated from the total hemoglobin concentration in the sample.
  • Concentrations of total hemoglobin include known methods such as the methemoglobin method, cyan methemoglobin method, azide methemoglobin method, sodium dodecyl sulfonate method, alkali hematin method, green chromophore formation method, and oxyhemoglobin method. .
  • a reagent such as potassium ferricyanide is reacted and a method using light by an antigen-antibody reaction using an anti-hemoglobin antibody as an antibody have been established.
  • the detection area of the second detection element is twice or more than the detection area of the third detection element. This is because the hemoglobin detected by the third detection element is present in a large amount in the blood, and the glycated hemoglobin or glycated albumin, which is a glycated product thereof, is at most 50% or less. Therefore, if the detection area of the second detection element is twice or more larger than the third detection area, the detection reliability of hemoglobin and its saccharified product is improved.
  • they are 2 times or more and 10 times or less, More preferably, they are 2 times or more and 5 times or less, More preferably, they are 2 times or more and 3 times or less, Especially preferably, they are 2 times or more and 2.5 times or less.
  • the sensor of the present invention preferably has a biological fluid inlet 301 and a path 302 that connects the inlet to the first detection element 401, the second detection element 402, and the third detection element 403, respectively.
  • a biological fluid inlet 301 and a path 302 that connects the inlet to the first detection element 401, the second detection element 402, and the third detection element 403, respectively.
  • the injection port is provided in any part of the sensor body. Although it is provided on the upper surface of the upper substrate 20 in FIG. 1, the present invention is not limited thereto, and may be the side surface of the upper substrate 20 or the side surface of the substrate 10.
  • a depression 304 may be provided at a location corresponding to the injection port 301 provided in the upper substrate 20.
  • the path is connected from the inlet to the first detection element and the second detection element.
  • the path is provided in a groove shape on the substrate 10, and the biological fluid injected from the injection port 301 accumulates in the depression 304 and flows from there to the path 302.
  • a groove having substantially the same shape as the path 302 may be provided at a position corresponding to the path 302 on the bonding surface of the upper substrate 20 to the substrate 10.
  • the size of the groove can be increased when the upper substrate 20 and the substrate 10 are bonded together.
  • the positional relationship between the inlet and the route is not limited to these.
  • a path may be provided in a tubular shape inside the upper substrate 20 so as to be digged from the inlet toward the first detection element and the second detection element.
  • a tubular route and a groove-like route may be used in combination. If the position of the injection port changes, the position where the path is provided also changes.
  • the injection port and path are made by processing the substrate.
  • the processing method greatly depends on the material. For example, if silicon or glass is used, fine processing using photolithography, laser processing, and the like are possible. In addition to these, if it is plastic, injection molding, imprinting, hot embossing, drilling and the like are also possible. However, in any case, the processing method is not particularly limited to these.
  • the shape of the channel is typically a groove shape or a tubular shape, but is not limited to these as long as it can flow a biological fluid.
  • the processed surface may be processed so that the biological fluid can be easily flowed.
  • the width of the path is not particularly limited, but is preferably about 1 ⁇ m to 1 mm.
  • the depth of the path is not particularly limited, but is preferably about 1 ⁇ m to 1 mm.
  • Examples of a method for bonding the substrate 10 and the upper substrate 20 include a method using an adhesive. Any adhesive may be used as long as it can form a liquid layer. For example, an ultraviolet curing type, a thermosetting type, and a two-component mixed type adhesive may be used. In consideration of the affinity with the substrate, an adhesive that can be applied uniformly with a thickness of about several micrometers is preferable. For example, if the substrate is a hydrophilic glass substrate, the adhesive is also preferably hydrophilic.
  • the substrate or the upper substrate is a glass substrate
  • a method of welding the inner surfaces of them using a laser and integrating them is also mentioned.
  • Various methods, such as capillary action, pumping, pressurization, and centrifugation, can be used to cause the biological fluid to flow through the path.
  • a biological fluid is a fluid that an organism has in the body in some form. Specific examples include blood, lymph, tissue fluid, body cavity fluid, digestive fluid, sweat, tears, runny nose, urine, semen, vaginal fluid, amniotic fluid, spinal fluid, synovial fluid, cell suspension and milk as they are. Can be used. Moreover, the sample which crushed or removed the cell component etc. previously from the biological sample may be sufficient. Examples of the digestive juice include saliva, gastric juice, bile, pancreatic juice, and intestinal juice.
  • the sensor including the semiconductor element of the present invention As a sample to be used for the sensor including the semiconductor element of the present invention, among biological fluids, blood, saliva, sweat, tears, urine and the like are preferable because of easy availability, and among them blood is more preferable because it contains a lot of biological information.
  • the biological substance other than glucose is not particularly limited as long as it is detected by the second detection element, and any substance can be used. Specifically, enzyme, antigen, antibody, hapten, hapten antibody, peptide, oligopeptide, polypeptide (protein), hormone, nucleic acid, oligonucleotide, biotin, biotinylated protein, avidin, streptavidin, lipid, steroid, sugar Saccharides such as oligosaccharides and polysaccharides (excluding glucose), low molecular compounds, high molecular compounds, inorganic substances and complexes thereof, viruses, bacteria, cells, living tissues, and substances constituting these.
  • the low molecular weight compound is not particularly limited, and examples thereof include a gaseous compound at normal temperature and normal pressure such as ammonia and methane emitted from a living body and a solid compound such as uric acid.
  • a gaseous compound at normal temperature and normal pressure such as ammonia and methane emitted from a living body
  • a solid compound such as uric acid.
  • solid compounds such as uric acid are used.
  • proteins examples include PSA, hCG, IgE, BNP, NT-proBNP, AFP, CK-MB, PIVKA II, CA15-3, CYFRA, anti-p53, troponin T, procalcitonin, hemoglobin, HbA1c, glycoalbumin, Examples include apolipoprotein and C-reactive protein (CRP).
  • proteins include PSA, hCG, IgE, BNP, NT-proBNP, AFP, CK-MB, PIVKA II, CA15-3, CYFRA, anti-p53, troponin T, procalcitonin, hemoglobin, HbA1c, glycoalbumin
  • CRP C-reactive protein
  • viruses examples include HIV, influenza virus, hepatitis B virus, and hepatitis C virus.
  • bacteria examples include Chlamydia, Staphylococcus aureus, and enterohemorrhagic Escherichia coli.
  • hemoglobin, HbA1c, and glycoalbumin which are types of polypeptides, are preferable. This is because it can be a disease marker for diabetes, and it is significant to combine with a first detection element capable of detecting glucose.
  • Hemolysis When the biological fluid used for the measurement according to the present invention is blood, it is necessary to perform hemolysis of the blood. In 1 ⁇ L of blood, there are millions of red blood cells and several thousand to 10,000 white blood cells, so that hemoglobin in red blood cells cannot be detected as it is. Therefore, it is necessary to treat the cell membrane of red blood cells by damaging or lysing them by various factors such as physical, chemical, biological, etc. and causing hemoglobin or the like to leak out of the cells. This is called hemolysis.
  • Physiological factors include various mechanical stresses such as pressure and centrifugal force.
  • Typical hemolysis methods include the method of excessively negative pressure in the syringe during blood collection, the method of exposing to excessive centrifugal force during the centrifugation, and the method of agitating or foaming erythrocyte fluid roughly. is there.
  • a method of mixing red blood cells with a solution having a low osmotic pressure can also be used. Due to the difference in osmotic pressure, extracellular water continues to flow into the cell through the cell membrane, which is a semipermeable membrane, and finally erythrocytes are ruptured.
  • water, purified water, buffer solution, and the like can also be hemolytic agents.
  • Chemical factors include lipid dissolution or damage that constitutes the cell membrane due to various solvents and surfactants.
  • solvents and surfactants include alcohols such as methanol and ethanol, various organic solvents other than acetone, and soap.
  • Complement activation signal transduction begins when antibodies against erythrocytes bind or by another activation mechanism, and each component of complement is activated sequentially (cascade reaction) and finally penetrates the cell membrane. A channel-like protein complex is formed, and the cell membrane is perforated, causing hemolysis.
  • the hemolysis method applied to the present invention is not particularly limited, but an osmotic pressure method is preferable from the viewpoint of availability and cost.
  • hemolysis can be achieved by a method such as dilution by adding 2 to 100 times the volume of purified water to the blood volume.
  • the space for performing the hemolysis treatment is not particularly limited.
  • the hemolysis treatment may be performed before the injection port for injecting blood into the sensor, or may be performed between the injection port and the detection element. , Either or not.
  • the above-described path has a space for mixing blood and a hemolytic agent between the blood inlet and the second or third detection element.
  • the blood injected from the injection port and the hemolyzing agent are mixed in the space by allowing the hemolytic agent such as the surfactant, purified water, and buffer solution to exist in the space 303 in advance.
  • the mixed liquid flows into the semiconductor layer.
  • semiconductor element The semiconductor element included in the second or third detection element will be described in more detail.
  • One aspect of the semiconductor element used in the present invention includes a substrate, a first electrode, a second electrode, and a semiconductor layer, and the semiconductor layer contains carbon nanotubes (hereinafter referred to as CNT).
  • the semiconductor element further includes a third electrode and an insulating layer, and the third electrode is electrically connected to the first electrode, the second electrode, and the semiconductor layer by the insulating layer. Insulated and arranged.
  • FIG. 2 and 3 are schematic cross-sectional views showing examples of semiconductor elements.
  • a first electrode 103 and a second electrode 104 are formed on a substrate 10, and a semiconductor layer 111 is disposed between the first electrode 103 and the second electrode 104.
  • the third electrode 105 and the insulating layer 106 are formed on the substrate 10, and the first electrode 103 and the second electrode 104 are formed.
  • a semiconductor layer 111 containing CNT is disposed on the substrate.
  • the first electrode 103, the second electrode 104, and the third electrode 105 correspond to the source electrode, the drain electrode, and the gate electrode, respectively, and the insulating layer 106 corresponds to the gate insulating layer, and functions as an FET. .
  • Examples of the material used for the substrate 10 include inorganic materials such as silicon wafer, glass, and alumina sintered body, polyimide, polyester, polycarbonate, polysulfone, polyethersulfone, polyethylene, polyphenylene sulfide, polyparaxylene, aliphatic polyester, Examples include, but are not limited to, organic materials such as polyethylene terephthalate, polybutylene terephthalate, polypropylene, polyvinyl alcohol, polyvinyl chloride, polyvinylidene fluoride, polysiloxane, polyvinylphenol, and polyaramide, or a mixture of inorganic material powder and organic material. Is not to be done. These materials may be used alone, or a plurality of materials may be laminated or mixed.
  • inorganic materials such as silicon wafer, glass, and alumina sintered body, polyimide, polyester, polycarbonate, polysulfone, polyethersulfone, polyethylene, polyphenylene sulfide
  • the surface of the substrate 10 may be processed.
  • hydrophilic groups having no charge such as oligoethylene glycol chain and oligo (3,4-dihydroxyphenylalanine) and hydrophilic groups having both positive and negative charges such as phosphorylcholine group are effective.
  • a biological substance other than glucose is detected by selective interaction with another biological substance, which will be described later, in order to manufacture the sensor, a solution in which the biological substance is dissolved in the semiconductor layer
  • another sensitive substance is immobilized on the sensitive part.
  • the other biological substance is selectively immobilized on the sensitive part by suppressing the other biological substance from adhering to other than the sensitive part. Thereby, it is suppressed that biological related substances other than glucose are captured by another biological related substance at a place other than the sensitive part, selective detection in the sensitive part becomes dominant, and detection sensitivity is improved.
  • Examples of materials used for the first electrode 103, the second electrode 104, and the third electrode 105 include conductive metal oxides such as tin oxide, indium oxide, and indium tin oxide (ITO), platinum, gold, silver, Metals such as copper, iron, tin, zinc, aluminum, indium, chromium, titanium, lithium, sodium, potassium, cesium, calcium, magnesium, palladium, molybdenum, amorphous silicon, and polysilicon, and alloys thereof, copper iodide, And inorganic conductive materials such as copper sulfide, organic conductive materials such as polythiophene, polypyrrole, polyaniline, and polyethylenedioxythiophene and polystyrenesulfonic acid complexes, carbon nanotubes, nanocarbon materials such as graphene, and conductive carbon black Etc. That, without being limited thereto.
  • conductive metal oxides such as tin oxide, indium oxide, and indium tin oxide (ITO)
  • ITO
  • the nanocarbon material may be any of single-walled carbon nanotubes, double-walled carbon nanotubes, and multi-walled carbon nanotubes containing a metal type of 80% by weight or more. Among them, it is preferable to use double-walled carbon nanotubes in order to obtain high conductive properties.
  • These electrode materials may be used alone, or a plurality of materials may be laminated or mixed.
  • the first electrode 103 and the second electrode 104 are made of gold, platinum, palladium, organic, from the viewpoints of electrical resistance value, ease of film formation, film stability, and stability to aqueous solutions in contact with the sensor. It is preferably selected from conductive materials and nanocarbon materials. In particular, gold or carbon nanotubes are more preferable because the difference in work function with a semiconductor element containing carbon nanotubes is small, so that low power consumption driving is possible.
  • the width, thickness, interval, and arrangement of the first electrode 103 and the second electrode 104 are arbitrary.
  • the width is preferably 1 ⁇ m to 1 mm
  • the thickness is preferably 1 nm to 1 ⁇ m
  • the electrode spacing is preferably 1 ⁇ m to 10 mm.
  • the width and thickness of the first electrode 103 and the second electrode 104 may not be the same.
  • the shape of the electrode need not be a rectangular parallelepiped, and may be bent or comb-shaped.
  • the width, thickness, distance from the semiconductor layer, and arrangement of the third electrode 105 are arbitrary.
  • the width is preferably 1 ⁇ m to 1 mm
  • the thickness is preferably 1 nm to 1 ⁇ m
  • the distance from the semiconductor layer is preferably 1 ⁇ m to 10 cm.
  • an electrode having a width of 100 ⁇ m and a thickness of 500 nm is disposed at a distance of 2 mm from the semiconductor layer, but is not limited thereto.
  • the third electrode 105 is arranged in parallel with the second electrode 104, but may be arranged vertically or at any other angle.
  • the shape of the third electrode 105 is not limited to a straight line, and may be a curved line or a curved surface.
  • the third electrode 105 is not limited to being disposed immediately above the substrate, but may be disposed on another member disposed on the substrate.
  • Examples of the material used for the insulating layer 106 include inorganic materials such as silicon oxide and alumina, and organic polymers such as polyimide, polyvinyl alcohol, polyvinyl chloride, polyethylene terephthalate, polyvinylidene fluoride, polysiloxane, and polyvinylphenol (PVP).
  • inorganic materials such as silicon oxide and alumina
  • organic polymers such as polyimide, polyvinyl alcohol, polyvinyl chloride, polyethylene terephthalate, polyvinylidene fluoride, polysiloxane, and polyvinylphenol (PVP).
  • PVP polyvinylphenol
  • the film thickness of the insulating layer 106 is preferably 10 nm or more and 5 ⁇ m or less. More preferably, they are 50 nm or more and 3 micrometers or less, More preferably, they are 100 nm or more and 1 micrometer or less.
  • the film thickness can be measured by an atomic force microscope or an ellipsometry method.
  • the semiconductor layer 111 preferably contains CNT.
  • the semiconductor layer 111 may further include an organic semiconductor or an insulating material as long as the electrical characteristics of the CNT are not impaired.
  • the thickness of the semiconductor layer 111 is preferably 1 nm to 100 nm. By being within this range, it is possible to sufficiently extract changes in electrical characteristics due to interaction with the sensing target substance as electrical signals. More preferably, they are 1 nm or more and 50 nm or less, More preferably, they are 1 nm or more and 20 nm or less.
  • a method for forming the semiconductor layer 111 dry methods such as resistance heating vapor deposition, electron beam, sputtering, and CVD can be used.
  • a coating method is used from the viewpoint of manufacturing cost and adaptability to a large area. Is preferred.
  • the coating method includes a step of forming a semiconductor layer by coating a semiconductor component.
  • a spin coating method, a blade coating method, a slit die coating method, a screen printing method, a bar coater method, a mold method, a printing transfer method, a dip pulling method, an ink jet method, and the like can be preferably used.
  • the coating method can be selected according to the properties of the coating film to be obtained, such as control and orientation control.
  • the formed coating film may be annealed in the air, under reduced pressure, or in an inert gas atmosphere (in a nitrogen or argon atmosphere).
  • the current flowing between the source electrode and the drain electrode can be controlled by changing the applied gate voltage.
  • the mobility of the FET can be calculated using the following equation (a).
  • ⁇ ( ⁇ Id / ⁇ Vg) L ⁇ D / (W ⁇ ⁇ r ⁇ ⁇ ⁇ Vsd) (a)
  • Id is the current between the source and the drain
  • Vsd is the voltage between the source and the drain
  • Vg is the gate voltage
  • D is the thickness of the insulating layer
  • L is the channel length
  • W is the channel width
  • epsilon r is the ratio of the gate insulating layer
  • the dielectric constant and ⁇ are the dielectric constant of vacuum (8.85 ⁇ 10 ⁇ 12 F / m). Further, the on / off ratio can be obtained from the ratio between the maximum value of Id and the minimum value of Id.
  • CNT As the CNT, a single-layer CNT in which one carbon film (graphene sheet) is wound in a cylindrical shape, a two-layer CNT in which two graphene sheets are wound in a concentric circle, and a plurality of graphene sheets are concentric Any of multi-walled CNTs wound in a shape may be used, but single-walled CNTs are preferably used in order to obtain high semiconductor characteristics.
  • CNT can be obtained by an arc discharge method, a chemical vapor deposition method (CVD method), a laser ablation method, or the like.
  • the CNT contains 80% by weight or more of the semiconductor CNT. More preferably, it contains 95% by weight or more of semiconducting CNTs.
  • a known method can be used as a method for obtaining a semiconductor-type 80% by weight or more CNT. For example, a method of ultracentrifugation in the presence of a density gradient agent, a method of selectively attaching a specific compound to the surface of a semiconductor-type or metal-type CNT, and separating using a difference in solubility, a difference in electrical properties And a method of separation by electrophoresis or the like.
  • Examples of the method for measuring the content of the semiconductor CNT include a method of calculating from the absorption area ratio of the visible-near infrared absorption spectrum and a method of calculating from the intensity ratio of the Raman spectrum.
  • the length of the CNT is preferably shorter than the distance between the first electrode and the second electrode in the applied semiconductor element or sensor.
  • the average length of CNT depends on the channel length, it is preferably 2 ⁇ m or less, more preferably 1 ⁇ m or less.
  • the average length of CNT refers to the average length of 20 CNTs picked up randomly.
  • 20 CNTs are randomly picked up from images obtained by an atomic force microscope, a scanning electron microscope, a transmission electron microscope, or the like, and the average of their lengths is obtained. A method for obtaining the value is mentioned.
  • CNTs are distributed in length and may contain CNTs that are longer than between the electrodes. Therefore, it is preferable to add a step of making the CNTs shorter than the distance between the electrodes. For example, a method of cutting into short fibers by acid treatment with nitric acid, sulfuric acid or the like, ultrasonic treatment, or freeze pulverization is effective. Further, it is more preferable to use separation by a filter in view of improving purity.
  • the diameter of the CNT is not particularly limited, but is preferably 1 nm or more and 100 nm or less, and more preferably 50 nm or less.
  • the present invention it is preferable to provide a step of uniformly dispersing CNT in a solvent and filtering the dispersion with a filter.
  • a membrane filter is preferably used as the filter.
  • the pore diameter of the filter used for the filtration may be smaller than the channel length, and is preferably 0.5 ⁇ m or more and 10 ⁇ m or less.
  • Other methods for shortening CNT include acid treatment, freeze pulverization treatment, and the like.
  • the semiconductor layer of the present invention preferably contains carbon nanotubes having a high mobility and a large specific surface area.
  • conjugated polymer In the present invention, it is preferable that a conjugated polymer is attached to at least a part of the CNT surface.
  • the conjugated polymer prevents an unexpected change in electrical characteristics from directly contacting the sample solution with the semiconductor component, and also plays a role of assisting electron transfer of the semiconductor component by the conjugated system.
  • conjugated polymer examples include a polythiophene polymer, a polypyrrole polymer, a polyaniline polymer, a polyacetylene polymer, a poly-p-phenylene polymer, and a poly-p-phenylene vinylene polymer. Although it is mentioned, it is not specifically limited. As the polymer, those in which single monomer units are arranged are preferably used, but those obtained by block copolymerization or random copolymerization of different monomer units are also used. Further, graft-polymerized products can also be used.
  • a polythiophene polymer that is easy to adhere to CNT and easily forms a complex with CNT is particularly preferable.
  • the preferred molecular weight of the conjugated polymer is 800 or more and 100,000 or less in terms of number average molecular weight.
  • the polymer need not necessarily have a high molecular weight, and may be an oligomer composed of a linear conjugated system.
  • the conjugated polymer contains a side chain, and at least a part of the side chain is a hydroxyl group, a carboxy group, an amino group, a mercapto group, a sulfo group, a phosphonic acid group, an organic salt or an inorganic salt thereof, a formyl group.
  • Preferably containing at least one functional group selected from the group consisting of a maleimide group and a succinimide group Preferably containing at least one functional group selected from the group consisting of a maleimide group and a succinimide group, and particularly preferably containing at least one functional group selected from the group consisting of an amino group, a maleimide group and a succinimide group.
  • the amino group, maleimide group, and succinimide group may or may not have a substituent.
  • the substituent include an alkyl group, and this substituent may be further substituted.
  • These functional groups may be bonded to form a ring.
  • the other compound having the functional group may adhere to at least a part of the CNT surface.
  • the side chain in the present invention refers to a chain containing at least one carbon atom connected by substitution with an atom constituting the main chain of the conjugated polymer.
  • the term “containing a functional group in a side chain” means that the functional group is included at the end of the side chain, or that the functional group is branched from the side chain and includes the functional group.
  • a chain is a chain in which two or more atoms are connected in series. At this time, one of the atoms contained in the functional group can be included in the atoms constituting the molecular chain.
  • a group represented by CH 2 —COOH is linked to the main chain, this is a side chain containing a carboxy group.
  • This side chain preferably contains an alkylene group in at least a part of the chain.
  • the alkylene group may be directly bonded to the atoms constituting the conjugated polymer that is the main chain, or may be bonded via an ether bond, an ester bond, or the like.
  • the alkylene group includes, for example, a methylene group, an ethylene group, an n-propylene group, an isopropylene group, an n-butylene group, a sec-butylene group, a tert-butylene group, a cyclopropylene group, a cyclohexylene group, and a norbornylene group.
  • a divalent saturated aliphatic hydrocarbon group such as, may or may not have a substituent.
  • the additional substituent is not particularly limited, and examples thereof include an alkyl group, an alkoxy group such as a methoxy group and an ethoxy group, and these further have a substituent. May be.
  • carbon number of an alkylene group is not specifically limited, 1 or more and 20 or less are preferable from the point of availability or cost, More preferably, it is 1 or more and 8 or less.
  • conjugated polymer having the functional group in the side chain include the following structures.
  • n in each structure shows the number of repetitions, and is the range of 2 or more and 1000 or less.
  • the conjugated polymer may be a single polymer of each structure or a copolymer.
  • the copolymer of each structure and the structure which does not have a side chain may be sufficient.
  • the conjugated polymer used in the present invention can be synthesized by a known method.
  • a method of linking thiophene and a thiophene derivative in which an alkyl group having a carboxy group at the end is introduced into the side chain a halogenated thiophene derivative and thiophene boronic acid or thiophene boronic acid ester are used as palladium catalysts.
  • a method of coupling a halogenated thiophene derivative and a thiophene Grignard reagent under a nickel or palladium catalyst are examples of synthesize monomers.
  • thiophene when thiophene is linked to another unit having a functional group introduced, it can be coupled in the same manner using a halogenated unit.
  • a conjugated polymer can be obtained by introducing a polymerizable substituent at the terminal of the monomer thus obtained and allowing the polymerization to proceed under a palladium catalyst or a nickel catalyst.
  • the conjugated polymer used in the present invention preferably removes impurities such as raw materials and by-products used in the synthesis process.
  • impurities such as raw materials and by-products used in the synthesis process.
  • silica gel columnography, Soxhlet extraction, filtration, ion exchange, chelation, and the like can be used. Two or more of these methods may be combined.
  • a CNT composite is used as a semiconductor component in the semiconductor layer of the present invention
  • the CNT by attaching an organic substance to at least a part of the CNT surface, the CNT can be put into a solution without impairing the high electrical properties possessed by the CNT. It becomes possible to disperse uniformly. Further, a uniformly dispersed CNT film can be formed from a solution in which CNTs are uniformly dispersed by a coating method. Thereby, a high semiconductor characteristic is realizable.
  • (III) CNTs are predispersed in advance with ultrasonic waves, etc., and organic substances are added and mixed therewith, and (IV) organic substances and CNTs are placed in a solvent, and this mixed system is irradiated with ultrasonic waves.
  • the method of mixing etc. is mentioned. In the present invention, any method may be used, and any method may be combined.
  • the organic substance is not particularly limited, but specifically, polyvinyl alcohol, celluloses such as carboxymethyl cellulose, polyalkylene glycols such as polyethylene glycol, and acrylic resins such as polyhydroxymethyl methacrylate, poly Examples include conjugated polymers such as -3-hexylthiophene, polycyclic aromatic compounds such as anthracene derivatives and pyrene derivatives, and long-chain alkyl organic salts such as sodium dodecyl sulfate and sodium cholate.
  • a conjugated polymer is particularly preferred. If it is a conjugated polymer, the effect of uniformly dispersing CNT in the solution and the effect of high semiconductor properties are further improved without impairing the high electrical properties possessed by the CNTs.
  • the semiconductor layer may be treated with a reagent (referred to as “protective agent”) for preventing the approach and adsorption of substances other than the detection target substance.
  • a reagent referred to as “protective agent”
  • the protective agent may be physically adsorbed on the semiconductor layer, or may be introduced somewhere in the semiconductor layer through a bond.
  • Examples of the method for attaching the protective agent to the semiconductor layer include: (I) a method in which a semiconductor component is preliminarily dispersed with ultrasonic waves or the like, and a protective agent is added thereto and mixed; (II) a protective agent in a solvent. And a semiconductor component, and a method of mixing the mixed system by irradiating ultrasonic waves to this mixed system, (III) a method of immersing the semiconductor component coated on the substrate in a molten protective agent, and (IV) a protective agent in a solvent And a method of immersing the semiconductor component coated on the substrate in the solution.
  • any method may be used, and any method may be combined. From the viewpoint of detection sensitivity, a method of attaching a protective agent to a semiconductor component using a solid-liquid reaction such as (III) or (IV) is preferable.
  • the conjugated polymer and the protective agent may be the same compound or different compounds. From the viewpoint of detection sensitivity, different compounds are preferable.
  • the protective agent include proteins such as bovine serum albumin, casein, and skim milk, celluloses such as carboxymethyl cellulose, polyalkylene glycols such as polyethylene glycol, ethanolamine, and polyvinyl alcohol.
  • the order of attaching the conjugated polymer and the protective agent to the semiconductor component is not particularly limited, but it is preferable to attach the protective agent after attaching the conjugated polymer.
  • another biological substance that selectively interacts with the biological substance that is a sensing target substance is preferably fixed to the semiconductor layer.
  • another biological substance is referred to as “receptor”.
  • the receptor is not particularly limited as long as it can selectively interact with the sensing target substance, and any substance can be used. Specifically, enzyme, antigen, antibody, hapten, hapten antibody, peptide, oligopeptide, polypeptide (protein), hormone, nucleic acid, oligonucleotide, biotin, biotinylated protein, avidin, streptavidin, sugar, oligosaccharide, And saccharides such as polysaccharides, low-molecular compounds, high-molecular compounds, inorganic substances and complexes thereof, viruses, bacteria, cells, biological tissues, and substances constituting them.
  • enzyme antigen, antibody, hapten, hapten antibody, peptide, oligopeptide, polypeptide (protein), hormone, nucleic acid, oligonucleotide, biotin, biotinylated protein, avidin, streptavidin, sugar, oligosaccharide, And saccharides such as polysaccharides, low-mol
  • antibodies, aptamers, enzymes, low molecular compounds, proteins, and oligonucleotides are preferable, low molecular compounds, antibodies, aptamers, and enzymes are more preferable, and biotin, antibodies, and aptamers are particularly preferable.
  • low molecular weight compound examples include compounds having a molecular weight of about 100 to 1000, and biotin, pyrenebutanoic acid succinimide ester, pyrenebutanoic acid maleimide ester, and the like.
  • antibodies include anti-PSA, anti-hCG, anti-IgE, anti-BNP, anti-NT-proBNP, anti-AFP, anti-CK-MB, anti-PIVKA II, anti-CA15-3, anti-CA15-3, -CYFRA, anti-HIV, anti-troponin T, anti-procalcitonin, anti-HbA1c, anti-apolipoprotein, and anti-C reactive protein (CRP).
  • the IgG type is preferable, and an antibody having only a variable site (Fab) fragment is particularly preferable.
  • aptamers include oligonucleotide aptamers and peptide aptamers. Specific examples include IgE aptamer, PSA aptamer, and thrombin aptamer. Examples of the enzyme include glucose oxidase and peroxidase. Of these, biotin, anti-IgE, anti-PSA, and IgE aptamer are more preferable.
  • the method for immobilizing the receptor to the semiconductor layer is not particularly limited, but biologically related substances other than glucose and functional groups contained in the semiconductor layer, that is, hydroxyl group, carboxy group, amino group, mercapto group, sulfo group. It is preferable to utilize a reaction or interaction with at least one functional group selected from the group consisting of a group, a phosphonic acid group, an organic salt or an inorganic salt thereof, a formyl group, a maleimide group and a succinimide group.
  • a reaction or interaction between a biological substance other than glucose and a functional group contained in the semiconductor layer it is preferable to use a reaction or interaction between a biological substance other than glucose and a functional group contained in the semiconductor layer.
  • a bio-related substance other than glucose contains an amino group
  • examples thereof include a carboxy group, an aldehyde group, and a succinimide group.
  • a thiol group, a maleimide group and the like can be mentioned.
  • the carboxy group and the amino group can easily utilize the reaction or interaction with the receptor, making it easy to fix the receptor to the semiconductor layer. Therefore, it is preferable that the functional group contained in at least a part of the CNT is a carboxy group and an amino group.
  • reaction or interaction examples include chemical bond, hydrogen bond, ionic bond, coordination bond, electrostatic force, van der Waals force, etc., but are not particularly limited.
  • the type of functional group and the chemical structure of the receptor Appropriate selection may be made according to the situation. Further, if necessary, a part of the functional group and / or receptor may be converted into another suitable functional group and then fixed. Further, a linker such as terephthalic acid may be used between the functional group and the receptor.
  • the length of the functional group contained in the CNT is preferably short so that the receptor can be held close to the semiconductor component. This is because the sensing target substance is captured by the receptor closer to the semiconductor layer, and the detection signal becomes larger. More specifically, the length of the functional group contained in the CNT is preferably from 0.1 nm to 5 nm, more preferably from 0.15 nm to 3.1 nm, and particularly preferably from 0.3 nm to 1.6 nm.
  • the functional group contained in the CNT contains a bond having a high affinity with water.
  • a bond examples include an ether bond, a thioether bond, an ester bond, an amide bond, a thioester bond, a dithioester bond, an acid anhydride bond, and an imide bond.
  • an ether bond, an ester bond, an amide bond, and an imide bond are particularly preferable from the viewpoints of stability and affinity with water.
  • the ring structure may exist in the functional group which CNT contains.
  • the fixing process is not particularly limited, but a solution containing the receptor is dropped on the semiconductor layer containing CNTs, and after fixing the receptor while applying heating, cooling, vibration, etc. as necessary, excess components are removed.
  • cleaning or drying are mentioned.
  • the combination of the functional group / receptor / sensing target substance contained in CNT is, for example, carboxy group / T-PSA-mAb (monoclonal antibody for prostate specific antigen) / PSA.
  • IgE aptamer / IgE Combinations of biotin / avidin, stop preavidin / biotin, natriuretic peptide receptor / BNP (brain natriuretic peptide) and the like can be mentioned.
  • target substances having great significance to be detected together with glucose are hemoglobin, HbA1c, and glycoalbumin, and it is particularly preferable to use a sensor for detecting these.
  • the senor of the present invention includes at least a first detection element that detects glucose in a biological fluid and a second detection element that detects a biological substance other than glucose, and the second detection element. It is a small sensor that can be measured on the same substrate including a semiconductor element. Furthermore, even when the third detection element includes a semiconductor element, it is a small sensor that can be measured on the same substrate.
  • a sensor part containing a semiconductor element will be described in detail.
  • the sensor part includes a substrate, a first electrode, a second electrode, and a semiconductor layer, and the first electrode, the second electrode, and the semiconductor layer are formed on the substrate.
  • the semiconductor layer contains a semiconductor element disposed between the first electrode and the second electrode. Furthermore, it is preferable that the semiconductor layer has another biological substance that selectively interacts with a biological substance other than glucose.
  • a sensor including a semiconductor element formed as shown in FIG. 2 includes a first electrode 103 and a second electrode 104 when a substance to be detected or a solution, gas or solid containing the substance to be detected is disposed in the vicinity of the semiconductor layer 111.
  • the current value or electric resistance value flowing between the two changes. By measuring the change, the detection target substance can be detected.
  • the value of the current flowing through the semiconductor layer 111 can be controlled by the voltage of the third electrode 105. Accordingly, when the value of the current flowing between the first electrode 103 and the second electrode 104 when the voltage of the third electrode 105 is changed, a two-dimensional graph (IV graph) is obtained.
  • the detection target substance may be detected using part or all of the characteristic values, or the detection target substance may be detected using the ratio between the maximum current and the minimum current, that is, the on / off ratio. Furthermore, known electrical characteristics obtained from a semiconductor element such as resistance value, threshold voltage change, impedance, mutual conductance, and capacitance may be used.
  • the detection target substance may be used alone, or may be mixed with other substances or solvents.
  • a substance to be detected or a solution, gas or solid containing the substance to be detected is disposed in the vicinity of the semiconductor layer 111.
  • the electrical characteristics of the semiconductor layer 111 change due to the interaction between the semiconductor layer 111 and the substance to be detected, and this is detected as a change in any one of the electrical signals described above.
  • the senor of the present invention further includes a covering member that covers at least a part of the substrate on the substrate.
  • a covering member that covers at least a part of the substrate on the substrate.
  • FIGS. 5A and 5B it is preferable to include an upper substrate 20 that forms an internal space between the substrate 10 and the substrate 10 as shown in FIGS. 5A and 5B.
  • a broken line in the upper substrate 20 in FIG. 5A indicates a boundary between the upper substrate 20 and the internal space.
  • FIG. 5B is a cross-sectional view taken along line CC ′ of FIG. 5A and shows an internal space 108 between the substrate 10 and the upper substrate 20.
  • FIG. 6B is a cross-sectional view taken along line DD ′ of FIG. 6A.
  • the above-mentioned upper substrate or covering member is provided on a substrate, and a third electrode is provided on the surface of the upper substrate or covering member facing the semiconductor layer.
  • the substrate includes a substrate, a first electrode, a second electrode, and a semiconductor layer formed between the first electrode and the second electrode, and further includes an upper substrate or a covering member on the substrate,
  • a third electrode is provided on a surface of the substrate or covering member that faces the semiconductor layer, and the semiconductor layer has another biological substance that selectively interacts with a biological substance other than glucose.
  • a gas layer, a liquid layer, a solid layer, or a combination thereof may exist, Good.
  • FIG. 7 is a schematic cross-sectional view showing an example of a sensor portion containing the semiconductor element of the present invention.
  • the first electrode 103 and the second electrode 104 are formed on the substrate 10
  • the semiconductor layer 111 is disposed between the first electrode 103 and the second electrode 104
  • the upper substrate 20 is on the substrate 10.
  • the third electrode 105 is arranged on the upper substrate 20.
  • the arrangement of the third electrode 105 on the upper substrate 20 is not limited to the position immediately above the semiconductor layer, but may be an oblique upper side.
  • the upper substrate 20 is not limited to the upper surface portion when viewed from the semiconductor layer, and may be disposed on the side surface.
  • the third electrode 105 is not limited to being disposed on the upper substrate 20, and may be disposed on the substrate 10.
  • the material used for the upper substrate 20 or the covering member examples include inorganic materials such as silicon wafer, glass, and alumina sintered body, polyimide, polyester, polycarbonate, polysulfone, polyethersulfone, polyethylene, polyphenylene sulfide, and polyparaxylene. However, it is not limited to these. These materials may be used alone, or a plurality of materials may be laminated or mixed.
  • the manufacturing method of the sensor containing the 1st detection element 401 shown in FIG. 1 and the 2nd detection element 402 is shown.
  • the sensor manufacturing method includes a step of forming a semiconductor layer by applying and drying a semiconductor component on a substrate.
  • the manufacturing method is not limited to the following.
  • the first electrode 103 and the second electrode 104 are formed on the substrate 10.
  • the forming method include known methods such as metal deposition, spin coating method, blade coating method, slit die coating method, screen printing method, bar coater method, mold method, printing transfer method, immersion pulling method, and ink jet method.
  • the connection portion 102 and the wiring 107 may be formed by the same formation method as the formation method of the first electrode and the second electrode, or each may be formed in a lump.
  • connection part 102, the wiring 107 and the first electrode 103 are electrically connected by the second electrode 104, the wiring 107 and the connection part 102 through the semiconductor layer 111.
  • a power source and a detection unit are connected to the connection unit 102. Using this connection, a voltage can be applied between the electrodes from the power source, and an electrical signal generated in the semiconductor layer can be taken out from the connection portion.
  • the semiconductor layer 111 is formed.
  • a manufacturing method comprising: attaching a semiconductor layer to a compound containing a linking group on the semiconductor layer; and forming a bond between the linking group and another bio-related substance that selectively interacts with the bio-related substance. Is preferred.
  • a method for attaching a compound containing a linking group to the semiconductor layer for example, a method of vapor-depositing a compound containing a linking group in a vacuum, or by immersing the semiconductor layer in a solution in which the compound containing the linking group is dissolved.
  • a method for applying a compound containing a linking group to the semiconductor layer for example, a method of applying a compound containing a linking group to the semiconductor layer, and a method of applying a solution in which the compound containing the linking group is dissolved in the semiconductor layer.
  • Examples of the step of forming a bond between another biological substance that selectively interacts with the biological substance and the linking group include, for example, a method of causing another biological substance to collide with the semiconductor layer in a vacuum to cause a reaction. And a method in which the semiconductor layer is immersed in a solution in which another biological substance is dissolved, and a method in which a solution in which another biological substance is dissolved is applied to the semiconductor layer.
  • the formation of the semiconductor layer and the fixation of another biological substance may be performed separately or collectively.
  • a method of forming a semiconductor layer using a semiconductor component in which another biological substance is bonded or attached in advance through a linking group can be used.
  • the shape of the sensor As the shape of the sensor, the shape shown in FIG. 1 of the present invention is preferable. Specific shapes include a shape like a sensor chip used in a blood glucose level sensor and a portable cassette type. These shapes are preferable because the size of the main body having the power source to be connected and the analysis algorithm can be reduced.
  • a light source is required, and the device is enlarged because a unit for diffusing heat generated by the light source is required, but according to the present invention, a light source is not used.
  • the size can be reduced as compared with the conventional apparatus.
  • Another embodiment of the present invention includes a sensor having a detection element that detects at least one selected from the group consisting of hemoglobin, glycated hemoglobin, and glycated albumin, and the detection element includes a semiconductor element.
  • the detection element includes a semiconductor element.
  • the functional group / receptor / sensing target substance combination contained in the CNT complex in the semiconductor element is, for example, carboxy group / anti-human hemoglobin monoclonal antibody / hemoglobin, carboxy group, carboxy group / anti-antibody.
  • Examples include mouse hemoglobin A1c monoclonal antibody / glycohemoglobin, carboxy group / anti-human albumin antibody / albumin, and carboxy group / anti-glycoalbumin antibody / glycoalbumin.
  • blood as a measurement sample is injected into the sensor from the injection port 301.
  • the injected blood flows through the path 302 and branches in the middle of the first detection element direction and the second detection element direction.
  • glucose in the blood reacts with glucose degrading enzyme in the reaction layer 110. Utilizing this, the glucose concentration is measured.
  • the blood flowing toward the second detection element is mixed with a hemolytic agent in a space 303 in the middle.
  • HbA1c is taken out from the red blood cells.
  • the semiconductor layer 111 contains a CNT complex, and an anti-mouse hemoglobin A1c monoclonal antibody that selectively interacts with HbA1c is immobilized on the CNT complex.
  • HbA1c extracted from the red blood cells in the space 303 reaches the semiconductor layer 111, the value of the current flowing through the semiconductor layer 111 changes due to the interaction with the anti-mouse hemoglobin A1c monoclonal antibody. Using this, the HbA1c concentration is measured.
  • the blood flowing in the direction of the third detection element is mixed with the hemolytic agent in the space 303 in the middle. Thereby, hemoglobin is taken out from the red blood cells.
  • the semiconductor layer 201 contains a CNT complex, and an anti-hemoglobin antibody that selectively interacts with hemoglobin is immobilized on the CNT complex.
  • CNTs are as follows. SWCNT: Meijo Nano Carbon Co., Ltd., single-walled CNT, semiconducting CNT purity> 95% DWCNT: Two-layer CNT manufactured by Toray Industries, Inc. MWCNT: Multi-layer CNT, manufactured by Meijo Nanocarbon
  • P3HT poly-3-hexylthiophene
  • PBS phosphate buffered saline
  • BSA bovine serum albumin
  • IgE immunoglobulin
  • FBS fetal bovine serum
  • NT-proBNP human brain natriuretic peptide precursor N-terminal fragment
  • PBSE 1-pyrenebutanoic acid-N-hydroxysuccinimide ester
  • PET polyethylene terephthalate
  • PEN polyethylene naphthalate o-DCB: o-dichlorobenzene
  • the sensor shown in FIG. 1 was produced, and in Examples 14 to 27, the sensor shown in FIG. 9 was produced and used for evaluation.
  • the first detection element was produced in the same manner as the production method of the conventional blood glucose level sensor, and it was confirmed that it could be detected.
  • Example 1 Preparation of semiconductor solution Add 1.5 mg of CNT and 1.5 mg of P3HT into 15 mL of chloroform, and use an ultrasonic homogenizer (VCX-500, manufactured by Tokyo Rika Kikai Co., Ltd.) while cooling with ice at an output of 250 W. The mixture was ultrasonically stirred for 30 minutes to obtain CNT dispersion A (CNT complex concentration of 0.1 g / l with respect to the solvent). Next, a semiconductor solution for forming a semiconductor layer was prepared.
  • VCX-500 ultrasonic homogenizer
  • the CNT dispersion A was filtered using a membrane filter (pore size: 10 ⁇ m, diameter: 25 mm, Omnipore membrane manufactured by Millipore), and then a membrane filter (pore size: 3 ⁇ m, diameter: 25 mm, Omnipore membrane manufactured by Millipore) was used. And filtered. 45 mL of o-DCB was added to 5 mL of the obtained filtrate to obtain a semiconductor solution A (CNT complex concentration of 0.01 g / l with respect to the solvent).
  • the internal temperature was raised to 90 ° C., and a component mainly composed of methanol produced as a by-product was distilled off.
  • the bath was heated at 130 ° C. for 2.0 hours, the internal temperature was raised to 118 ° C., and a component mainly composed of water and propylene glycol monobutyl ether was distilled off, and then cooled to room temperature, and the solid content concentration was 26.0.
  • a weight percent polymer solution A was obtained.
  • polymer solution A 50 g of the obtained polymer solution A was weighed, mixed with 16.6 g of propylene glycol monobutyl ether (boiling point 170 ° C.), stirred at room temperature for 2 hours, and polymer solution B (solid content concentration 19.5 wt%) was obtained. Obtained.
  • the semiconductor element shown in FIG. 3 was fabricated. On the glass substrate 10 (film thickness 0.7 mm), gold was vacuum-deposited by 50 nm through a mask by a resistance heating method, and the first electrode 103 and the second electrode 104 were formed. The width (channel width) of the first electrode and the second electrode was 400 ⁇ m, and the distance (channel length) between the first electrode and the second electrode was 60 ⁇ m.
  • a semiconductor layer 111 is formed by dropping 400 pl of the semiconductor solution A produced by the method described in (1) above on the organic film on which the electrode is formed using an inkjet apparatus (manufactured by Cluster Technology Co., Ltd.), and a hot plate
  • the semiconductor device A was obtained by performing a heat treatment at 120 ° C.
  • the semiconductor layer was immersed overnight at 4 ° C. in a solution of Anti-HbA1c (manufactured by Funakoshi) at 0.01 ug / mL with 0.01 M PBS. Thereafter, the semiconductor layer was thoroughly rinsed with 0.01M PBS. Next, BSA (manufactured by Wako Pure Chemical Industries, Ltd.) 5.0 mg in 0.01 M PBS 5.0 mL was immersed for 2 hours. Thereafter, the semiconductor layer was sufficiently rinsed with 0.01 M PBS to obtain a semiconductor element in which the semiconductor layer was modified with Anti-HbA1c, which is a biological substance that selectively interacts with the sensing target substance, and BSA, which is a protective agent.
  • Anti-HbA1c manufactured by Funakoshi
  • BSA manufactured by Wako Pure Chemical Industries, Ltd.
  • Example 2 (1) Production of Semiconductor Element
  • Semiconductor element A was produced in the same manner as in Example 1. Next, the semiconductor layer was immersed in 1.0 mL of 1-pyrenebutanoic acid-N-hydroxysuccinimide ester (anaspec Co., Ltd., PBSE) in 6.0 mL of acetonitrile (Wako Pure Chemical Industries, Ltd.) for 1 hour. . Thereafter, the semiconductor layer was sufficiently rinsed with acetonitrile and methanol (manufactured by Wako Pure Chemical Industries, Ltd.). The semiconductor layer was immersed overnight at 4 ° C.
  • Example 3 Fabrication of Semiconductor Element
  • the semiconductor element shown in FIG. 3 was fabricated.
  • a glass substrate 10 (film thickness 0.7 mm) was subjected to ultraviolet ozone treatment (photo surface processor, PL30-200, manufactured by SEN LIGHTTS CORP.) For 30 minutes, and a polyethylene glycol chain-containing silane coupling agent (SIH6188, manufactured by Gelest) It was immersed in a 10 wt% ethanol solution for 1 hour. After washing with ethanol for 30 seconds, the organic film 106 was formed by drying at 120 ° C. for 30 minutes. The first electrode 103 and the second electrode 104 were formed on the organic film by mask vapor deposition so that the film thickness was 50 nm.
  • the width (channel width) of the first electrode and the electric two electrode was 400 ⁇ m, and the distance (channel length) between the first electrode and the electric two electrode was 60 ⁇ m.
  • a semiconductor layer 4 is formed by dropping 400 pl of the semiconductor solution A produced by the method described in (1) above on the organic film on which the electrode is formed using an inkjet apparatus (manufactured by Cluster Technology Co., Ltd.), and a hot plate A heat treatment was performed at 150 ° C. for 30 minutes under a nitrogen stream to obtain a semiconductor element B.
  • the semiconductor layer was immersed in a 1.0 mL solution of 6.0 mg of 1-pyrenebutanoic acid-N-hydroxysuccinimide ester (manufactured by Anaspec Co., Ltd.) in acetonitrile (manufactured by Wako Pure Chemical Industries, Ltd.) for 1 hour. Thereafter, the semiconductor layer was sufficiently rinsed with acetonitrile and methanol (manufactured by Wako Pure Chemical Industries, Ltd.). The semiconductor layer was immersed overnight at 4 ° C. in a solution of Anti-HbA1c (manufactured by Funakoshi) made 100 ug / mL with 0.01 M PBS.
  • Anti-HbA1c manufactured by Funakoshi
  • the semiconductor layer was thoroughly rinsed with 0.01M PBS.
  • BSA manufactured by Wako Pure Chemical Industries, Ltd.
  • 5.0 mg in 0.01 M PBS 5.0 mL was immersed for 30 minutes.
  • the semiconductor layer was sufficiently rinsed with 0.01 M PBS to obtain a semiconductor element in which the semiconductor layer was modified with Anti-HbA1c, which is a biological substance that selectively interacts with the sensing target substance, and BSA, which is a protective agent.
  • Example 4 (1) Fabrication of semiconductor device A semiconductor layer was formed in the same manner as in Example 3 except that Anti-HbA1c fragment antibody (Fab) was used instead of Anti-HbA1c.
  • Fab Anti-HbA1c fragment antibody
  • Evaluation as a sensor In order to evaluate the semiconductor element produced above as a sensor, the measurement was performed in the same manner as in Example 1. The results are shown in Table 1. Only when HbA1c was added, a current value increase of 6.5% was observed from the current value before the addition.
  • Example 5 Fabrication of semiconductor element A semiconductor element was obtained by forming a semiconductor layer in the same manner as in Example 4 except that single-walled carbon nanotubes (SWCNT) containing 90% by weight of a metal mold were used instead of gold. .
  • SWCNT single-walled carbon nanotubes
  • Example 5 Evaluation as a sensor In order to evaluate the semiconductor element produced above as a sensor, the measurement was performed in the same manner as in Example 1. The results are shown in Table 1. Only when HbA1c was added, a current value increase of 5.8% was observed from the current value before the addition.
  • Example 6 (1) Production of Semiconductor Element A semiconductor element was obtained by forming a semiconductor layer in the same manner as in Example 4 except that double-walled carbon nanotubes (DWCNT) were used instead of gold. (2) Evaluation as a sensor In order to evaluate the semiconductor element produced above as a sensor, the measurement was performed in the same manner as in Example 1. The results are shown in Table 1. Only when HbA1c was added, the current value increased by 6.0% from the current value before the addition.
  • DWCNT double-walled carbon nanotubes
  • Example 7 (1) Production of Semiconductor Element A semiconductor layer was formed in the same manner as in Example 4 except that multi-walled carbon nanotubes (MWCNT) were used instead of gold to obtain a semiconductor element.
  • MWCNT multi-walled carbon nanotubes
  • Evaluation as a sensor In order to evaluate the semiconductor element produced above as a sensor, the measurement was performed in the same manner as in Example 1. The results are shown in Table 1. Only when HbA1c was added, a current value increase of 5.7% was observed from the current value before the addition.
  • Example 8 (1) Preparation of semiconductor solution Semiconductor solution B (CNT complex concentration 0.01 g / l with respect to the solvent) was carried out in the same manner as in Example 1 except that the compound represented by formula (69) was used instead of P3HT. It was. (2) Fabrication of Semiconductor Element A semiconductor layer was formed in the same manner as in Example 4 except that the semiconductor solution B was used instead of the semiconductor solution A to obtain a semiconductor element. (3) Evaluation as sensor In order to evaluate the semiconductor element produced above as a sensor, measurement was performed in the same manner as in Example 1. The results are shown in Table 1. Only when HbA1c was added, a current value increase of 6.6% was observed from the current value before the addition.
  • Example 9 (1) Preparation of semiconductor solution Semiconductor solution C (CNT complex concentration 0.01 g / l with respect to the solvent) was carried out in the same manner as in Example 1 except that the compound represented by formula (71) was used instead of P3HT. It was. (2) Production of Semiconductor Element A semiconductor layer was formed in the same manner as in Example 4 except that the semiconductor solution C was used in place of the semiconductor solution A to obtain a semiconductor element. (3) Evaluation as sensor In order to evaluate the semiconductor element produced above as a sensor, measurement was performed in the same manner as in Example 1. The results are shown in Table 1. Only when HbA1c was added, a current value increase of 6.9% was observed from the current value before the addition.
  • Example 10 (1) Fabrication of semiconductor device A semiconductor layer was formed in the same manner as in Example 9 except that anti-glycoalbumin was used instead of Anti-HbA1c. (2) Evaluation as a sensor In order to evaluate the semiconductor element produced above as a sensor, the measurement was performed in the same manner as in Example 10. The results are shown in Table 1. Only when glycoalbumin was added, the current value increased by 8.1% from the current value before the addition.
  • Example 13 (1) Production of Semiconductor Device A semiconductor layer was formed in the same manner as in Example 10 except that anti-NT-proBNP was used instead of anti-glycoalbumin to obtain a semiconductor device. (2) Evaluation as sensor In order to evaluate the semiconductor element produced above as a sensor, measurement was performed in the same manner as in Example 12. The results are shown in Table 1. Only when NT-proBNP was added, the current value increased by 7.5% from the current value before the addition.
  • Example 14 (1) Production of Semiconductor Element The second detection element was produced in the same manner as in Example 9. In addition, a semiconductor layer was formed in the same manner as in Example 10 except that anti-hemoglobin was used instead of anti-glycoalbumin, thereby producing a third detection element. (2) Evaluation as a sensor (second detection element) The same results as in Example 9 were obtained. (Third detection element) The semiconductor layer of the manufactured semiconductor element was immersed in 100 ⁇ l of 0.01M PBS, and the value of current flowing between the first electrode and the second electrode was measured. For the measurement, a semiconductor characteristic evaluation system 4200-SCS type (manufactured by Keithley Instruments Co., Ltd.) was used.
  • 60 ⁇ m after the start of measurement 20 ⁇ l of 5 ⁇ g / mL BSA-0.01M PBS solution, 75 ⁇ m after 5 ⁇ g / mL HbA1c (manufactured by Funakoshi) -0.01 M PBS solution 20 ⁇ l, 90 ⁇ m after 5 ⁇ g / mL hemoglobin (manufactured by Funakoshi) -0 20 ⁇ l of 0.01 M PBS solution was added to 0.01 M PBS soaked in the semiconductor layer.
  • Table 1 Only when hemoglobin was added, a current value increase of 3.2% was observed from the current value before the addition.
  • Example 15 (1) Production of Semiconductor Element The second detection element was produced in the same manner as in Example 9. Further, a semiconductor layer was formed in the same manner as in Example 14 except that the width (channel width) of the first electrode and the electric two electrode was 400 ⁇ m and the interval (channel length) between the first electrode and the electric two electrode was 40 ⁇ m. A semiconductor element was manufactured to obtain a third detection element. (2) Evaluation as a sensor (second detection element) The same results as in Example 9 were obtained. (Third detection element) In order to evaluate the semiconductor element produced above as a sensor, measurement was performed in the same manner as in Example 14. The results are shown in Table 1. Only when hemoglobin was added, a current value increase of 4.0% was observed from the current value before the addition.
  • Example 16 (1) Production of Semiconductor Element The second detection element was produced in the same manner as in Example 9. Further, a semiconductor layer was formed in the same manner as in Example 14 except that the width (channel width) of the first electrode and the electrode 2 was 400 ⁇ m and the interval (channel length) between the first electrode and the electrode 2 was 30 ⁇ m. A semiconductor element was manufactured to obtain a third detection element. (2) Evaluation as a sensor (second detection element) The same results as in Example 9 were obtained. (Third detection element) In order to evaluate the semiconductor element produced above as a sensor, measurement was performed in the same manner as in Example 14. The results are shown in Table 1. Only when hemoglobin was added, a current value increase of 4.8% was observed from the current value before the addition.
  • Example 17 (1) Production of Semiconductor Element The second detection element was produced in the same manner as in Example 9. Further, a semiconductor layer was formed in the same manner as in Example 14 except that the width (channel width) of the first electrode and the electrode 2 was 400 ⁇ m and the interval (channel length) between the first electrode and the electrode 2 was 25 ⁇ m. A semiconductor element was manufactured to obtain a third detection element. (2) Evaluation as a sensor (second detection element) The same results as in Example 9 were obtained. (Third detection element) In order to evaluate the semiconductor element produced above as a sensor, measurement was performed in the same manner as in Example 14. The results are shown in Table 1. Only when hemoglobin was added, a current value increase of 5.1% was observed from the current value before the addition.
  • Example 18 (1) Production of Semiconductor Element The second detection element was produced in the same manner as in Example 9. Further, a semiconductor layer was formed in the same manner as in Example 16 except that the substrate was made of glass, a semiconductor element was produced, and a third detection element was obtained. (2) Evaluation as a sensor (second detection element) The same results as in Example 9 were obtained. (Third detection element) In order to evaluate the semiconductor element produced above as a sensor, measurement was performed in the same manner as in Example 14. The results are shown in Table 1. Only when hemoglobin was added, a current value increase of 4.5% was observed from the current value before the addition.
  • Example 19 (1) Production of Semiconductor Element The second detection element was produced in the same manner as in Example 9. A semiconductor layer was formed in the same manner as in Example 16 except that the substrate was a PET film, a semiconductor element was produced, and a third detection element was obtained. (2) Evaluation as a sensor (second detection element) The same results as in Example 9 were obtained. (Third detection element) In order to evaluate the semiconductor element produced above as a sensor, measurement was performed in the same manner as in Example 14. The results are shown in Table 1. Only when hemoglobin was added, a current value increase of 4.7% was observed from the current value before the addition.
  • Example 20 (1) Production of Semiconductor Element The second detection element was produced in the same manner as in Example 9. Further, a semiconductor layer was formed in the same manner as in Example 16 except that the substrate was a PEN film, a semiconductor element was produced, and a third detection element was obtained. (2) Evaluation as a sensor (second detection element) The same results as in Example 9 were obtained. (Third detection element) In order to evaluate the semiconductor element produced above as a sensor, measurement was performed in the same manner as in Example 14. The results are shown in Table 1. Only when hemoglobin was added, a current value increase of 4.6% was observed from the current value before the addition.
  • Example 21 (1) Production of Semiconductor Element The second detection element was produced in the same manner as in Example 9. Further, in the same manner as in Example 16, a semiconductor layer was formed, a semiconductor element was produced, and a third detection element was obtained. (2) Evaluation as a sensor (second detection element) The same results as in Example 9 were obtained. (Third detection element) The semiconductor layer of the produced semiconductor element was immersed in 100 ⁇ l of FBS (manufactured by BioWest), and the value of current flowing between the first electrode and the second electrode was measured. For the measurement, a semiconductor characteristic evaluation system 4200-SCS type (manufactured by Keithley Instruments Co., Ltd.) was used.
  • FBS manufactured by BioWest
  • Vsd a voltage between the first electrode and the second electrode
  • Vg a voltage between the first electrode and the third electrode
  • Example 22 (1) Production of Semiconductor Element The second detection element was produced in the same manner as in Example 9. Further, in the same manner as in Example 16, a semiconductor layer was formed, a semiconductor element was produced, and a third detection element was obtained. (2) Evaluation as a sensor (second detection element) The semiconductor layer of the produced semiconductor element was immersed in 100 ⁇ l of FBS (manufactured by BioWest), and the value of current flowing between the first electrode and the second electrode was measured. For the measurement, a semiconductor characteristic evaluation system 4200-SCS type (manufactured by Keithley Instruments Co., Ltd.) was used.
  • FBS manufactured by BioWest
  • Vsd a voltage between the first electrode and the second electrode
  • Vg a voltage between the first electrode and the third electrode
  • 60 minutes after the start of the measurement 20 ⁇ l of a 5 ⁇ g / mL BSA-FBS solution was added to FBS soaked with 20 ⁇ l of healthy human blood in a semiconductor layer 75 minutes later.
  • the results are shown in Table 1. Only when a healthy person added blood, an increase in current value of 8.0% was observed from the current value before addition, and blood HbA1c was selectively detected.
  • the semiconductor layer of the produced semiconductor element was immersed in 100 ⁇ l of FBS (manufactured by BioWest), and the value of current flowing between the first electrode and the second electrode was measured.
  • FBS manufactured by BioWest
  • a semiconductor characteristic evaluation system 4200-SCS type manufactured by Keithley Instruments Co., Ltd.
  • Example 23 (1) Production of Semiconductor Element
  • the second detection element was produced in the same manner as in Example 9. Also, implementation was performed except that anti-hemoglobin was used instead of Anti-HbA1c, the width of the first electrode and the electric two electrode (channel width) was 400 ⁇ m, and the distance between the first electrode and the electric two electrode (channel length) was 120 ⁇ m.
  • a semiconductor layer was formed, a semiconductor element was produced, and a third detection element was obtained.
  • Evaluation as a sensor (second detection element) The same results as in Example 9 were obtained.
  • (Third detection element) In order to evaluate the semiconductor element produced above as a sensor, measurement was performed in the same manner as in Example 14. The results are shown in Table 1. Only when hemoglobin was added, a current value increase of 1.7% was observed from the current value before the addition.
  • Example 24 (1) Production of Semiconductor Element The second detection element was produced in the same manner as in Example 9. Further, a semiconductor layer was formed in the same manner as in Example 14 except that the width (channel width) of the first electrode and the electrode 2 was 400 ⁇ m and the interval (channel length) between the first electrode and the electrode 2 was 600 ⁇ m. A semiconductor element was manufactured to obtain a third detection element. (2) Evaluation as a sensor (second detection element) The same results as in Example 9 were obtained. (Third detection element) Measurement was carried out in the same manner as in Example 14 in order to evaluate the semiconductor element produced above as a sensor. With each addition of BSA, HbA1c, and hemoglobin, a current value increase of 0.3% was observed from the current value before the addition. The results are shown in Table 1.
  • Example 25 Production of semiconductor element The first detection element was produced by the same production method as that of an existing blood glucose level sensor. The second detection element was produced in the same manner as in Example 9. Further, in the same manner as in Example 16, a semiconductor layer was formed, a semiconductor element was produced, and a third detection element was obtained.
  • Example 26 (1) Production of semiconductor element The first detection element was produced by the same production method as that of an existing blood glucose level sensor.
  • the second detection element was produced in the same manner as in Example 9. Further, in the same manner as in Example 17, a semiconductor layer was formed, a semiconductor element was produced, and a third detection element was obtained.
  • (2) Evaluation as sensor The sensor shown in FIG. 9 was prepared, and 200 ⁇ l of FBS (manufactured by BioWest) was filled in the flow path, and the current value flowing between the electrodes of the second detection element and the third detection element was measured. For the measurement, a semiconductor characteristic evaluation system 4200-SCS type (manufactured by Keithley Instruments Co., Ltd.) was used.
  • Example 27 (1) Production of semiconductor element The first detection element was produced by the same production method as that of an existing blood glucose level sensor. The second detection element was produced in the same manner as in Example 9. Further, a semiconductor layer was formed in the same manner as in Example 14 to produce a semiconductor element, thereby obtaining a third detection element.
  • Comparative Example 1 HbA1c and hemoglobin were measured using a 7180 Hitachi automatic analyzer described in the examples of Japanese Patent Application Laid-Open No. 2015-165827 without using semiconductor elements for the second and third detection elements.
  • the analysis device is an optical instrument and the measures are large, it is difficult to perform electrical measurement using the same chip as glucose measurement.
  • the sensor using the present invention can be applied to various types of sensing such as chemical analysis, physical analysis, and biological analysis, and is particularly suitably used as a medical sensor or biosensor.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Electrochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Diabetes (AREA)
  • Ecology (AREA)
  • Biophysics (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)

Abstract

La présente invention aborde le problème de fourniture d'un capteur compact avec lequel il est possible d'effectuer des mesures simultanées de glucose et de substances biologiquement intéressantes autres que le glucose. La présente invention concerne un capteur caractérisé en ce qu'il comporte au moins : un premier élément de détection pour détecter le glucose dans un liquide biologique ; et un deuxième élément de détection pour détecter des substances biologiquement intéressantes autres que le glucose, le deuxième élément de détection comprenant un élément à semi-conducteur.
PCT/JP2016/083127 2015-11-09 2016-11-08 Capteur Ceased WO2017082253A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2017550336A JPWO2017082253A1 (ja) 2015-11-09 2016-11-08 センサ

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2015-219207 2015-11-09
JP2015219207 2015-11-09

Publications (1)

Publication Number Publication Date
WO2017082253A1 true WO2017082253A1 (fr) 2017-05-18

Family

ID=58695405

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2016/083127 Ceased WO2017082253A1 (fr) 2015-11-09 2016-11-08 Capteur

Country Status (3)

Country Link
JP (1) JPWO2017082253A1 (fr)
TW (1) TW201716779A (fr)
WO (1) WO2017082253A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3531131A4 (fr) * 2016-10-24 2019-12-25 Toray Industries, Inc. Capteur à semi-conducteur, son procédé de fabrication et capteur composite
CN111225958A (zh) * 2017-07-27 2020-06-02 哈佛大学校长及研究员协会 导电防污涂层组合物
CN113588750A (zh) * 2021-07-16 2021-11-02 成都云芯医联科技有限公司 一种同时测量血红蛋白与糖化血红蛋白的电化学测试卡及其制作方法

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112505115B (zh) * 2020-12-17 2025-05-06 东北农业大学 一种用于检测毛油中磷脂的三维光敏电极的制备及检测方法

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006242900A (ja) * 2005-03-07 2006-09-14 Mitsubishi Chemicals Corp センサユニット及び反応場セルユニット並びに分析装置
JP2006317360A (ja) * 2005-05-16 2006-11-24 National Institute Of Advanced Industrial & Technology 竹型カーボンナノチューブを用いたバイオセンサ
WO2007094354A1 (fr) * 2006-02-14 2007-08-23 National Institute Of Advanced Industrial Science And Technology CAPTEUR D'HÉMOGLOBINE A1c
JP2008082988A (ja) * 2006-09-28 2008-04-10 Hokkaido Univ 多段階増幅を利用した検出方法
CN101358982A (zh) * 2007-08-01 2009-02-04 中国科学院电子学研究所 基于场效应管的糖化血红蛋白免疫传感器
WO2014069551A1 (fr) * 2012-10-31 2014-05-08 日立化成株式会社 Puce de capteur, et dispositif de mesure et procédé de mesure l'utilisant
US20140170675A1 (en) * 2011-06-06 2014-06-19 Yeda Research And Development Co. Ltd Protein detector based on molecular controlled semiconductor resistor
WO2015012186A1 (fr) * 2013-07-25 2015-01-29 東レ株式会社 Composite à base de nanotubes de carbone, dispositif semi-conducteur, et capteur les utilisant

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006242900A (ja) * 2005-03-07 2006-09-14 Mitsubishi Chemicals Corp センサユニット及び反応場セルユニット並びに分析装置
JP2006317360A (ja) * 2005-05-16 2006-11-24 National Institute Of Advanced Industrial & Technology 竹型カーボンナノチューブを用いたバイオセンサ
WO2007094354A1 (fr) * 2006-02-14 2007-08-23 National Institute Of Advanced Industrial Science And Technology CAPTEUR D'HÉMOGLOBINE A1c
JP2008082988A (ja) * 2006-09-28 2008-04-10 Hokkaido Univ 多段階増幅を利用した検出方法
CN101358982A (zh) * 2007-08-01 2009-02-04 中国科学院电子学研究所 基于场效应管的糖化血红蛋白免疫传感器
US20140170675A1 (en) * 2011-06-06 2014-06-19 Yeda Research And Development Co. Ltd Protein detector based on molecular controlled semiconductor resistor
WO2014069551A1 (fr) * 2012-10-31 2014-05-08 日立化成株式会社 Puce de capteur, et dispositif de mesure et procédé de mesure l'utilisant
WO2015012186A1 (fr) * 2013-07-25 2015-01-29 東レ株式会社 Composite à base de nanotubes de carbone, dispositif semi-conducteur, et capteur les utilisant

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NAOKO TSUKUBE: "On Chip-gata Flow Immunoassay ni yoru HbAlc no Kan'i Sokuteiho no Kaihatsu", THE ELECTROCHEMICAL SOCIETY OF JAPAN KOEN YOSHISHU DAI 71 KAI TAIKAI, 2013, pages 98 *

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3531131A4 (fr) * 2016-10-24 2019-12-25 Toray Industries, Inc. Capteur à semi-conducteur, son procédé de fabrication et capteur composite
CN111225958A (zh) * 2017-07-27 2020-06-02 哈佛大学校长及研究员协会 导电防污涂层组合物
JP2020528950A (ja) * 2017-07-27 2020-10-01 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 電気伝導性防汚コーティング組成物
CN111225958B (zh) * 2017-07-27 2023-06-20 哈佛大学校长及研究员协会 导电防污涂层组合物
JP7365330B2 (ja) 2017-07-27 2023-10-19 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 電気伝導性防汚コーティング組成物
CN113588750A (zh) * 2021-07-16 2021-11-02 成都云芯医联科技有限公司 一种同时测量血红蛋白与糖化血红蛋白的电化学测试卡及其制作方法
CN113588750B (zh) * 2021-07-16 2024-01-19 成都云芯医联科技有限公司 一种同时测量血红蛋白与糖化血红蛋白的电化学测试卡及其制作方法

Also Published As

Publication number Publication date
TW201716779A (zh) 2017-05-16
JPWO2017082253A1 (ja) 2018-08-23

Similar Documents

Publication Publication Date Title
Verma et al. Anti-IL8/AuNPs-rGO/ITO as an immunosensing platform for noninvasive electrochemical detection of oral cancer
Veetil et al. Development of immunosensors using carbon nanotubes
Zhou et al. Novel graphene biosensor based on the functionalization of multifunctional nano-bovine serum albumin for the highly sensitive detection of cancer biomarkers
Augustine et al. Amine-functionalized MoO3@ RGO nanohybrid-based biosensor for breast cancer detection
Xu et al. Flexible biosensors for the impedimetric detection of protein targets using silk-conductive polymer biocomposites
Khan et al. Detection of prostate specific antigen (PSA) in human saliva using an ultra-sensitive nanocomposite of graphene nanoplatelets with diblock-co-polymers and Au electrodes
JP6922222B2 (ja) 半導体素子、その製造方法およびそれを用いたセンサ
TWI760377B (zh) 半導體感測器及其製造方法以及複合感測器
Hampitak et al. A point-of-care immunosensor based on a quartz crystal microbalance with graphene biointerface for antibody assay
EP3026014A1 (fr) Composite à base de nanotubes de carbone, dispositif semi-conducteur, et capteur les utilisant
Wang et al. Avidin–biotin technology in gold nanoparticle-decorated graphene field effect transistors for detection of biotinylated macromolecules with ultrahigh sensitivity and specificity
JP6634827B2 (ja) カーボンナノチューブ複合体、半導体素子およびその製造方法ならびにそれを用いたセンサ
Nishitani et al. Polymeric nanofilter biointerface for potentiometric small-biomolecule recognition
Bhasin et al. Virus bioresistor (VBR) for detection of bladder cancer marker DJ-1 in urine at 10 pM in one minute
WO2017082253A1 (fr) Capteur
Lee et al. Fabrication and Functionalisation of Nanocarbon‐Based Field‐Effect Transistor Biosensors
Tiwari et al. Advanced bioelectronic materials
Supraja et al. Smartphone-powered, ultrasensitive, and selective, portable and stable multi-analyte chemiresistive immunosensing platform with PPY/COOH-MWCNT as bioelectrical transducer: Towards point-of-care TBI diagnosis
US20240002679A1 (en) Applications, methods, and tools for development, rapid preparation and deposition of a nanocomposite coating on surfaces for diagnostic devices including electrochemical sensors
Song et al. Highly effective and efficient self-assembled multilayer-based electrode passivation for operationally stable and reproducible electrolyte-gated transistor biosensors
Palaniappan et al. Functionalized Carbon Nanotubes: Applications in Biosensing
Paruthi et al. Functionalized Nanomaterials for Designing Nano/Micro Biologically Sensitive Field‐Effect Transistors (Bio‐FETs)
Uludağ Anıl et al. MIP-based sensing strategies for the diagnosis of prostate and lung cancers
임재흥 A Biosensor platform based on the Carbon Nanotube Network for detecting antibody antigen reaction
Yáñez-Sedeño Orive et al. Multiplexed Electrochemical Immunosensors for Clinical Biomarkers

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16864214

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2017550336

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16864214

Country of ref document: EP

Kind code of ref document: A1